We have consistently observed that like other normal somatic tissue ce
lls, human T lymphocytes manifest a finite proliferative capacity in c
ulture in vitro. When measured in population doublings (PD), this aver
ages about 35 PD for T-cell clones (TCC) derived from mature periphera
l T cells of young adults and about 20 PD more for TCC derived from T-
cell precursors in their bone marrow. We believe that alterations in s
urface marker phenotypes and corresponding functional changes observed
in these human TCC as they progress through their finite lifespans in
vitro can provide valuable information on processes of T-cell immunos
enescence in vivo. They may also provide a model system for studying w
ays of modulating the ageing process to delay or prevent immunosenesce
nce in the elderly and the chronically infected or possibly to acceler
ate immunosenescence in organ transplantation.